EUCTR2010-018901-12-AT进行中（未招募）不适用
Placebo controlled study on effects of vitamin D supplementation in type 1 diabetic subjects on immunological, endocrine and metabolic parameters: Step 2 of the Austrian Diabetes Prevention Programme (ADPP-002)
Medical University Graz, Department of Internal Medicine, Div. Endocrinology and Metabolism0 个研究点开始时间: 2010年9月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Informed consent
- •Healthy volunteers with type 1 diabetic
- •Age of at least 6 years
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Hypercalcemia (>2,65mmol/L)
- •Nursing women
- •Any disease that requires continuous treatment with medications
- •Intake of medication as part of another clinical trial
研究者
相似试验
进行中（未招募）
1 期
Placebo controlled study on effects of vitamin D supplementation in healthy women and men on immunological, endocrine and metabolic parametershealthy volunteers. The intended indication for the investigated product is prevention and treatment of immunological (e.g. type 1 diabetes), endocrine (e.g. endocrine hypertension), metabolic (e.g. dyslipidemia) and cardiovascular diseases.EUCTR2009-015523-91-ATMedizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin
进行中（未招募）
不适用
A randomized placebo controlled trial of vitamin D3 supplementation to a vulnerable patientsgroup susceptible to uppertract respiratory infections.Patients with primary or secondary immunodeficiencies and/or patients who have an increased incidence of airborn infections more than 42 infectionsday /year.EUCTR2009-011758-16-SEKarolinska University Hospital Huddinge
进行中（未招募）
1 期
Prospective, placebo-controlled trial of vitamin D supplementation in patients with low-levels of 25-OH vitamin D to evaluate changes in markers of cardiovascular riskEUCTR2007-007474-33-ATDr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin100
尚未招募
不适用
Vitamin D and Type 2 Diabetes MellitusCTRI/2022/10/046633niversity College of Medical Sciences ang GTB Hospital
已完成
3 期
Effect of supplementation in treatment of women with cervical intraepithelial neoplasia 2 and 3IRCT201601045623N65Vice chancellor for research, Kashan University of Medical Sciences58